Summary: Cagrilintide and retatrutide are investigational injectable medicines being studied for obesity and type 2 diabetes in men, targeting multiple hormonal pathways to reduce appetite, improve blood glucose control, and increase energy expenditure, but neither is currently licensed in the UK
Ideally, these risk factors should be assessed and minimized in advance, so the surgery or procedure can safely proceed. The odds for aspiration is greatest in the first weeks after a GLP-1 med is prescribed, since the delay in stomach emptying is more pronounced then
Key References Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al
This process triggers your bodys natural healing response, gently exfoliating damaged skin cells and revealing a smoother, brighter, and more youthful complexion within days